(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

VBI VACCINES

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

VBI VACCINES

ST13

US500000087433019

Class

5, 42

Filing

87433019

Registration

6337513

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

58

Latest update

05/05/2026

Trademark type

Combined

Nice classes

5, 42

Filing date

05/02/2017

Registration date

05/04/2021

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

05/04/2021

Last transaction

05/05/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use, Foreign priority

Drawing code

3

Owner type

03

Owner location

Ottawa, Ontario, CA

Examiner

MAHONEY, PAULA M

Law office

N10

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the words "VBI VACCINES"; to the left of this wording is a circular design, comprised of irregular sized dark and light lines,.

Holders and representatives

Holders

Variation Biotechnologies Inc.

Representatives

Todd Braverman Todd Braverman & Associates, P.C. dba Trademarkauthority

Technical classification

Nice Classes

Class 5Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparationsvaccines used in the prevention and treatment of infectious diseases and cancer

Class 42

Pharmaceutical preparation collaborative research and development program; drug and vaccine formulation services; research and laboratory testing into the formulation of vaccines on behalf of othersanalytical reports

Publications

History of USPTO decisions and trademark events.

58 publications found

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

05/04/2026

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

09/24/2025

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

09/24/2025

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

09/24/2025

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

09/24/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

05/04/2021

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

02/16/2021

PUBO

PUBLISHED FOR OPPOSITION

02/16/2021

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

01/27/2021

CORV

REVIEW OF CORRESPONDENCE COMPLETE

01/15/2021

APET

ASSIGNED TO PETITION STAFF

01/12/2021

EPPA

TEAS POST PUBLICATION AMENDMENT RECEIVED

10/30/2020

DOCK

ASSIGNED TO EXAMINER

03/02/2020

ZZZX

PREVIOUS ALLOWANCE COUNT WITHDRAWN

11/07/2019

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

10/22/2019

PUBO

PUBLISHED FOR OPPOSITION

10/22/2019

PBCR

WITHDRAWN FROM PUB - OG REVIEW QUERY

10/21/2019

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

10/02/2019

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

09/17/2019

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

09/16/2019

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

09/16/2019

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

09/04/2019

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

03/08/2019

GNSL

LETTER OF SUSPENSION E-MAILED

03/08/2019

CNSL

SUSPENSION LETTER WRITTEN

03/08/2019

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/07/2019

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/07/2019

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

02/28/2019

GNS2

NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED

11/29/2018

GNSI

INQUIRY TO SUSPENSION E-MAILED

11/29/2018

CNSI

SUSPENSION INQUIRY WRITTEN

11/29/2018

RCCK

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION

11/29/2018

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

05/23/2018

GNSL

LETTER OF SUSPENSION E-MAILED

05/23/2018

CNSL

SUSPENSION LETTER WRITTEN

05/23/2018

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/18/2018

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/18/2018

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

05/18/2018

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

05/15/2018

GNSL

LETTER OF SUSPENSION E-MAILED

05/15/2018

CNSL

SUSPENSION LETTER WRITTEN

05/15/2018

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

04/19/2018

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

04/19/2018

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

04/17/2018

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

02/14/2018

GNSL

LETTER OF SUSPENSION E-MAILED

02/14/2018

CNSL

SUSPENSION LETTER WRITTEN

02/14/2018

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

02/13/2018

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

02/13/2018

ALIE

ASSIGNED TO LIE

02/11/2018

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

02/01/2018

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

08/07/2017

GNRT

NON-FINAL ACTION E-MAILED

08/07/2017

CNRT

NON-FINAL ACTION WRITTEN

08/07/2017

DOCK

ASSIGNED TO EXAMINER

07/30/2017

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

05/09/2017

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

05/06/2017

NWAP

NEW APPLICATION ENTERED

05/05/2017

Continuous trademark protection

Get notified about every new filing that threatens VBI VACCINES or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.